Showing results (621-630 of 11,010) with videos related to

Sort By:
Pageof 1,101
Bioinformatics (Oxford, England)|February 16, 2020
MichelaNglo: sculpting protein views on web pages without codingMatteo P Ferla, Alistair T Pagnamenta, David Damerell, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 17, 1997
Cerebellar axial postural tremorP Brown, J C Rothwell, J M Stevens, et al.
British Journal of Pharmacology|August 1, 1988
The interaction of substituted benzamides with brain benzodiazepine binding sites in vitroR W Horton, S Lowther, J Chivers, et al.
The American Journal of Tropical Medicine and Hygiene|July 1, 1979
Improvements in routine xenodiagnosis with first instar Dipetalogaster maximus (Uhler 1894) (Triatominae)P D Marsden, A C Barreto, C C Cuba, et al.
The Journal of Physiology|July 1, 1990
Cutaneous effects on presynaptic inhibition of flexor Ia afferents in the human forearmK Nakashima, J C Rothwell, B L Day, et al.
Annals of Neurology|July 1, 1992
Dystonia induced by combined treatment with L-dopa and MK-801 in parkinsonian monkeysN M Rupniak, S Boyce, M J Steventon, et al.
Brain : a Journal of Neurology|April 1, 1996
Clinical and physiological features of epilepsia partialis continua. Cases ascertained in the UKO C Cockerell, J Rothwell, P D Thompson, et al.
Neuropharmacology|June 1, 1984
Alterations in different populations of striatal dopamine receptors produced by 18 months continuous administration of cis- or trans-flupenthixol to ratsK Murugaiah, S Fleminger, M D Hall, et al.
Clinical Neuropathology|January 1, 1982
Morphologic studies on adult neuronal-ceroid lipofuscinosis (NCL)H H Goebel, H Braak, D Seidel, et al.
Clinical Neuropharmacology|February 1, 1989
The antiparkinsonian activity of CQA 206-291, a new D2 dopamine receptor agonistJ A Temlett, N P Quinn, C D Marsden, et al.
Pageof 1,101